ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
EML333
|
730 |
307K |
2 |
28/11/18 |
28/11/18 |
ASX - By Stock
|
730
|
307K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
EML333
|
730 |
307K |
0 |
28/11/18 |
28/11/18 |
ASX - By Stock
|
730
|
307K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
EML333
|
730 |
307K |
12 |
28/11/18 |
28/11/18 |
ASX - By Stock
|
730
|
307K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
EML333
|
730 |
307K |
0 |
27/11/18 |
27/11/18 |
ASX - By Stock
|
730
|
307K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
EML333
|
730 |
307K |
4 |
27/11/18 |
27/11/18 |
ASX - By Stock
|
730
|
307K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
HIV Wonder Drug BIT225
|
|
EML333
|
730 |
307K |
5 |
27/11/18 |
27/11/18 |
ASX - By Stock
|
730
|
307K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
3 |
18/11/18 |
18/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
18/11/18 |
18/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
18/11/18 |
18/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
3 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
2 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
10 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
2 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
3 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
6 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
7 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
4 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
5 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
2 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
2 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
3 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
1 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
EML333
|
13K |
6.3M |
9 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
13K
|
6.3M
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
0 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
16 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
16
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
EML333
|
13K |
6.3M |
2 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
EML333
|
13K |
6.3M |
6 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
13K
|
6.3M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
EML333
|
13K |
6.3M |
3 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
9 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
EML333
|
1.0K |
391K |
5 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
1.0K
|
391K
|
5
|
|